Global Diabetic Macular Edema Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Diabetic Macular Edema Market Analysis

  • Pharmaceutical
  • Upcoming Report
  • Jan 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

In recent years, the diabetic macular edema (DME) market is anticipated to grow rapidly during the forecast period. Diabetic macular edema (DME) is characterized by fluid accumulation in the macula, which is the region of the retina important for vision. Edema can result from the leakage of plasma contents into the surrounding area, causing the accumulation. Diabetic macular edema is one of the primary causes of blindness in diabetic patients, affecting around 12% of type 1 diabetes patients and 28% of type 2 diabetic patients in developing nations in 2011. Controlling blood sugar levels, or glycaemia, lipid levels, and renal function is the conventional treatment for diabetic macular edema. The Diabetes Control and Complications Trial (DCCT) found that individuals who received aggressive glycaemic treatment had a 2.3 percent lower risk of DME.

Filled Map Analysis

Frequently Asked Questions

The market is segmented based on Global Diabetic Macular Edema (DME) Market Segmentation, By Type (Focal Diabetic Macular Edema (DME), Diffuse Diabetic Macular Edema (DME)), Treatment (Laser Therapy, Anti-VEGF Agents, Steroids, Surgical, Others), Route of Administration (Intravitreal Injections, Intravitreal Implants, Others), Diagnosis (Fluorescein Angiography, Fundus Imaging, Optical Coherence Tomography (OCT), Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2032 .
The Global Diabetic Macular Edema Market size was valued at USD 3.33 USD Billion in 2024.
The Global Diabetic Macular Edema Market is projected to grow at a CAGR of 3.36% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.